Search

everythinglearnresearchcommunity

for

Search:↓

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Azathioprine may be an effective treatment for severe hair loss.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Baricitinib successfully treated severe hair loss.

The boy had severe facial swelling and scalp infection after using his mother's shampoo.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

A new mouse model helps understand and find treatments for alopecia areata.